Sign in
MAIA Stock Price, Chart, Stats & News
MAIA Biotechnology, Inc.
Save
MAIA Biotechnology, Inc. (MAIA) does not currently pay a dividend.
–
Market cap
–
Current P/E
–
Forward P/E
MAIA chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -0.23% |
ROE | -3.76% |
D/E | – |
Interest coverage ratio | – |
MAIA valuation
P/E | – |
P/S | – |
P/B | 0.02x |
P/CF | -0.00x |
P/FCF | -0.00x |
P/OCF | -0.00x |
PEG | -0.28x |
EV multiple | -602.63x |
About
MAIA Biotechnology, Inc. is a clinical-stage biotech firm dedicated to discovering, developing, and commercializing treatments for various cancers, with a primary focus on non-small cell lung cancer. The company's leading experimental compound, THIO, is an investigational drug candidate that utilizes a unique dual mechanism by targeting telomeres and stimulating an immune response. Established in 2018, the enterprise maintains its headquarters in Chicago, Illinois.
Similar securities
Based on sector and market capitalization
Report issue